Vincristine, Topotecan, and Cyclophosphamide With or Without Bevacizumab in Treating Young Patients With Refractory or First Recurrent Extracranial Ewing Sarcoma

This study has been completed.

Sponsor:

Collaborator:

Information provided by:

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00516295

First received: August 14, 2007

Last updated: November 20, 2010

Last verified: November 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	January 2010 (Final data collection date for primary outcome measure)